GLP1R and type 2 diabetes mellitus: Liraglutide treatment (GLP‐1R agonists, 3.0 mg daily) with over twenty‐four weeks is well tolerated and leads to fat mass reduction, particularly in android fat, while also improving the skeletal muscle index in patients with T2DM.833